2005
$50M
from 10 investors over 10 rounds
MAP Pharmaceuticals raised $50M on March 28, 2007
Investors: Sky Ventures, The D. E. Shaw Group, Perseus, Brookside Capital Inc and Bay City Capital
MAP Pharmaceuticals raised $25M on January 31, 2006
Investors: Sky Ventures, Bay City Capital and Perseus
MAP Pharmaceuticals raised $30M on September 7, 2004
Investors: Sky Ventures and Bay City Capital